104 related articles for article (PubMed ID: 1854611)
21. Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features.
Ménard S; Squicciarini P; Luini A; Sacchini V; Rovini D; Tagliabue E; Veronesi P; Salvadori B; Veronesi U; Colnaghi MI
Br J Cancer; 1994 Jun; 69(6):1126-9. PubMed ID: 7911032
[TBL] [Abstract][Full Text] [Related]
22. [Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].
Göhring UJ; Scharl A; Ahr A
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):177-83. PubMed ID: 8682282
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and immunochemical analysis of a breast carcinoma associated antigen defined by the monoclonal antibody NCRC-11.
Price MR
Arch Geschwulstforsch; 1987; 57(3):177-80. PubMed ID: 2441681
[TBL] [Abstract][Full Text] [Related]
24. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
[TBL] [Abstract][Full Text] [Related]
26. Prognostic relevance of serum hyaluronan levels in patients with breast cancer.
Ponting J; Howell A; Pye D; Kumar S
Int J Cancer; 1992 Dec; 52(6):873-6. PubMed ID: 1459727
[TBL] [Abstract][Full Text] [Related]
27. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study.
Ostrowski JL; Sawan A; Henry L; Wright C; Henry JA; Hennessy C; Lennard TJ; Angus B; Horne CH
J Pathol; 1991 May; 164(1):75-81. PubMed ID: 2056391
[TBL] [Abstract][Full Text] [Related]
28. Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study.
Hayes DF; Mesa-Tejada R; Papsidero LD; Croghan GA; Korzun AH; Norton L; Wood W; Strauchen JA; Grimes M; Weiss RB
J Clin Oncol; 1991 Jul; 9(7):1113-23. PubMed ID: 2045853
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective study.
Spyratos F; Martin PM; Hacène K; Andrieu C; Romain S; Floiras JL; Magdelénat H
Breast Cancer Res Treat; 1994 Jan; 29(1):85-95. PubMed ID: 8018965
[TBL] [Abstract][Full Text] [Related]
30. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.
Galea MH; Athanassiou E; Bell J; Dilks B; Robertson JF; Elston CW; Blamey RW; Ellis IO
J Pathol; 1991 Nov; 165(3):221-7. PubMed ID: 1722247
[TBL] [Abstract][Full Text] [Related]
31. Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer.
Schmitt M; Thomssen C; Ulm K; Seiderer A; Harbeck N; Höfler H; Jänicke F; Graeff H
Br J Cancer; 1997; 76(3):306-11. PubMed ID: 9252196
[TBL] [Abstract][Full Text] [Related]
32. Pepsinogen C is a new prognostic marker in primary breast cancer.
Vizoso F; Sánchez LM; Díez-Itza I; Merino AM; López-Otín C
J Clin Oncol; 1995 Jan; 13(1):54-61. PubMed ID: 7799043
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
34. [Basal and myoepithelial phenotype of metastatic mammary carcinomas. A prognostic factor in the palliative situation?].
Mainka P; Kahlert S; Kirchner T; Mayr D; Diebold J
Pathologe; 2008 Nov; 29 Suppl 2():363-9. PubMed ID: 18807040
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
36. Heat-shock protein 70 as a prognostic marker in node-negative breast cancer.
Thanner F; Sütterlin MW; Kapp M; Rieger L; Kristen P; Dietl J; Gassel AM; Müller T
Anticancer Res; 2003; 23(2A):1057-62. PubMed ID: 12820347
[TBL] [Abstract][Full Text] [Related]
37. Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications.
Honda Y; Aruga T; Yamashita T; Miyamoto H; Horiguchi K; Kitagawa D; Idera N; Goto R; Kuroi K
Jpn J Clin Oncol; 2015 Aug; 45(8):713-8. PubMed ID: 25981620
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
[TBL] [Abstract][Full Text] [Related]
39. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Buck A; Schirrmeister H; Kühn T; Shen C; Kalker T; Kotzerke J; Dankerl A; Glatting G; Reske S; Mattfeldt T
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1317-23. PubMed ID: 12271413
[TBL] [Abstract][Full Text] [Related]
40. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
